Trial Profile
Pharmacokinetics, pharmacodynamics and tolerability of vildagliptin (10, 25, 50 mg/day) in Japanese patients with type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2011
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Novartis Pharma
- 14 Jan 2011 New trial record